These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 24654943)

  • 1. Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells.
    Wolfram J; Suri K; Huang Y; Molinaro R; Borsoi C; Scott B; Boom K; Paolino D; Fresta M; Wang J; Ferrari M; Celia C; Shen H
    J Microencapsul; 2014; 31(5):501-7. PubMed ID: 24654943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice.
    Yang H; Chen D; Cui QC; Yuan X; Dou QP
    Cancer Res; 2006 May; 66(9):4758-65. PubMed ID: 16651429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells.
    Yang HS; Kim JY; Lee JH; Lee BW; Park KH; Shim KH; Lee MK; Seo KI
    Food Chem Toxicol; 2011 Feb; 49(2):527-32. PubMed ID: 21134410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
    Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
    Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-17-92a cluster promotes autophagy induction in response to celastrol treatment in prostate cancer cells.
    Guo J; Mei Y; Li K; Huang X; Yang H
    Biochem Biophys Res Commun; 2016 Sep; 478(2):804-10. PubMed ID: 27501757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis.
    Kuchta K; Xiang Y; Huang S; Tang Y; Peng X; Wang X; Zhu Y; Li J; Xu J; Lin Z; Pan T
    Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):156-164. PubMed ID: 28195223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrol.
    Huang Y; Zhou D; Hang T; Wu Z; Liu J; Xu Q; Xie X; Zuo J; Wang Z; Zhou Y
    Anticancer Drugs; 2012 Jun; 23(5):515-24. PubMed ID: 22343423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Celastrol on growth inhibition of U937 leukemia cells through the regulation of the Notch1/NF-kappaB signaling pathway in vitro.
    Wang XN; Wu Q; Yang X; Zhang LS; Wu YP; Lu C
    Chin J Cancer; 2010 Apr; 29(4):385-90. PubMed ID: 20346213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoencapsulation of natural triterpenoid celastrol for prostate cancer treatment.
    Sanna V; Chamcheu JC; Pala N; Mukhtar H; Sechi M; Siddiqui IA
    Int J Nanomedicine; 2015; 10():6835-46. PubMed ID: 26586945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Celastrol induced DNA damage, cell cycle arrest, and apoptosis in human rheumatoid fibroblast-like synovial cells.
    Xu Z; Wu G; Wei X; Chen X; Wang Y; Chen L
    Am J Chin Med; 2013; 41(3):615-28. PubMed ID: 23711145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies.
    Wang C; Dai S; Zhao X; Zhang Y; Gong L; Fu K; Ma C; Peng C; Li Y
    Biomed Pharmacother; 2023 Jul; 163():114882. PubMed ID: 37196541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Biological Evaluation of a Series of Novel Celastrol Derivatives with Amino Acid Chain.
    Pang C; Luo J; Liu C; Wu X; Wang D
    Chem Biodivers; 2018 May; 15(5):e1800059. PubMed ID: 29633499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP450s-Activity Relations of Celastrol to Interact with Triptolide Reveal the Reasons of Hepatotoxicity of
    Jin C; Wu Z; Wang L; Kanai Y; He X
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31181731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways.
    Mou H; Zheng Y; Zhao P; Bao H; Fang W; Xu N
    Toxicol In Vitro; 2011 Aug; 25(5):1027-32. PubMed ID: 21466843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.
    Hou W; Liu B; Xu H
    Eur J Med Chem; 2020 Mar; 189():112081. PubMed ID: 31991334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells.
    Chen G; Zhang X; Zhao M; Wang Y; Cheng X; Wang D; Xu Y; Du Z; Yu X
    BMC Cancer; 2011 May; 11():170. PubMed ID: 21569548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MVA pathway genes expressions and accumulation of celastrol in Tripterygium wilfordii suspension cells in response to methyl jasmonate treatment.
    Liu YJ; Zhao YJ; Su P; Zhang M; Tong YR; Hu TY; Huang LQ; Gao W
    J Asian Nat Prod Res; 2016 Jul; 18(7):619-28. PubMed ID: 26785825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Pharmacokinetics of Celastrol via Long-Circulating Liposomal Delivery for Intravenous Administration.
    Wang B; Shen J; Zhou C; Wang X; Wang S; Hou R
    Int J Nanomedicine; 2024; 19():5707-5718. PubMed ID: 38882540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells.
    Thangapazham RL; Puri A; Tele S; Blumenthal R; Maheshwari RK
    Int J Oncol; 2008 May; 32(5):1119-23. PubMed ID: 18425340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.